752 related articles for article (PubMed ID: 26824873)
1. The Evolution of Pressurized Metered-Dose Inhalers from Early to Modern Devices.
Roche N; Dekhuijzen PN
J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):311-27. PubMed ID: 26824873
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
[TBL] [Abstract][Full Text] [Related]
3. Advances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite technology.
Acerbi D; Brambilla G; Kottakis I
Pulm Pharmacol Ther; 2007; 20(3):290-303. PubMed ID: 16890465
[TBL] [Abstract][Full Text] [Related]
4. Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology.
Kleinstreuer C; Shi H; Zhang Z
J Aerosol Med; 2007; 20(3):294-309. PubMed ID: 17894536
[TBL] [Abstract][Full Text] [Related]
5. The rejuvenated pressurised metered dose inhaler.
Bell J; Newman S
Expert Opin Drug Deliv; 2007 May; 4(3):215-34. PubMed ID: 17489650
[TBL] [Abstract][Full Text] [Related]
6. Co-suspension delivery technology in pressurized metered-dose inhalers for multi-drug dosing in the treatment of respiratory diseases.
Ferguson GT; Hickey AJ; Dwivedi S
Respir Med; 2018 Jan; 134():16-23. PubMed ID: 29413503
[TBL] [Abstract][Full Text] [Related]
7. A review of the development of Respimat Soft Mist Inhaler.
Dalby R; Spallek M; Voshaar T
Int J Pharm; 2004 Sep; 283(1-2):1-9. PubMed ID: 15363496
[TBL] [Abstract][Full Text] [Related]
8. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients.
Darbà J; Ramírez G; Sicras A; Francoli P; Torvinen S; Sánchez-de la Rosa R
Int J Chron Obstruct Pulmon Dis; 2015; 10():2335-45. PubMed ID: 26604733
[TBL] [Abstract][Full Text] [Related]
9. Inhalatory therapy training: a priority challenge for the physician.
Melani AS
Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
[TBL] [Abstract][Full Text] [Related]
10. Novolizer: how does it fit into inhalation therapy?
Magnussen H
Curr Med Res Opin; 2005; 21 Suppl 4():S39-46; discussion S47. PubMed ID: 16138944
[TBL] [Abstract][Full Text] [Related]
11. [Chinese expert consensus on standardized inhaler device application in stable chronic airway diseases (2023)].
Inhalation Therapy and Respiratory Rehabilitation Group, Respiratory Equipment Committee of China Association of Medical Equipment
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1055-1067. PubMed ID: 37914418
[TBL] [Abstract][Full Text] [Related]
12. Variability in Delivered Dose from Pressurized Metered-Dose Inhaler Formulations Due to a Delay Between Shake and Fire.
Hatley RH; Parker J; Pritchard JN; von Hollen D
J Aerosol Med Pulm Drug Deliv; 2017 Feb; 30(1):71-79. PubMed ID: 27635793
[TBL] [Abstract][Full Text] [Related]
13. Importance of inhaler devices in the management of airway disease.
Virchow JC; Crompton GK; Dal Negro R; Pedersen S; Magnan A; Seidenberg J; Barnes PJ
Respir Med; 2008 Jan; 102(1):10-9. PubMed ID: 17923402
[TBL] [Abstract][Full Text] [Related]
14. Aerosol devices and asthma therapy.
Berger W
Curr Drug Deliv; 2009 Jan; 6(1):38-49. PubMed ID: 19418954
[TBL] [Abstract][Full Text] [Related]
15. A comparison of lung deposition patterns between different asthma inhalers.
Newman SP
J Aerosol Med; 1995 Sep; 8 Suppl 3():S21-6; discussion S27. PubMed ID: 10157895
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
[TBL] [Abstract][Full Text] [Related]
17. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
[TBL] [Abstract][Full Text] [Related]
18. A Randomized, Crossover Trial Evaluating Patient Handling, Preference, and Ease of Use of the Fluticasone Propionate/Formoterol Breath-Triggered Inhaler.
Bell D; Mansfield L; Lomax M
J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):425-434. PubMed ID: 28683212
[TBL] [Abstract][Full Text] [Related]
19. Optimizing drug delivery in COPD: The role of inhaler devices.
Rogliani P; Calzetta L; Coppola A; Cavalli F; Ora J; Puxeddu E; Matera MG; Cazzola M
Respir Med; 2017 Mar; 124():6-14. PubMed ID: 28284323
[TBL] [Abstract][Full Text] [Related]
20. Integration of dose counters in pressurized metered-dose inhalers for patients with asthma and chronic obstructive pulmonary disease: review of evidence.
Kaur I; Aggarwal B; Gogtay J
Expert Opin Drug Deliv; 2015 Aug; 12(8):1301-10. PubMed ID: 25564302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
